Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer

Autor: Versteijne, E., Dam, J.L. van, Suker, M., Janssen, Q.P., Groothuis, K., Akkermans-Vogelaar, J.M., Besselink, M.G., Bonsing, B.A., Buijsen, J., Busch, O.R., Creemers, G.J.M., Dam, R.M. van, Eskens, F.A.L.M., Festen, S., Groot, J.W.B. de, Koerkamp, B.G., Hingh, I.H. de, Homs, M.Y.V., Hooft, J.E. van, Kerver, E.D., Luelmo, S.A.C., Neelis, K.J., Nuyttens, J., Paardekooper, G.M.R.M., Patijn, G.A., Sangen, M.J.C. van der, Vos-Geelen, J. de, Wilmink, J.W., Zwinderman, A.H., Punt, C.J., Tienhoven, G. van, Eijck, C.H.J. van, Dutch Pancreatic Canc Grp

Publikováno v: Journal of Clinical Oncology, 40(11), 1220-1230. American Society of Clinical Oncology
Versteijne, E, van Dam, J L, Suker, M, Janssen, Q P, Groothuis, K, Akkermans-Vogelaar, J M, Besselink, M G, Bonsing, B A, Buijsen, J, Busch, O R, Creemers, G-J M, van Dam, R M, Eskens, F A L M, Festen, S, de Groot, J W B, Groot Koerkamp, B, de Hingh, I H, Homs, M Y V, van Hooft, J E, Kerver, E D, Luelmo, S A C, Neelis, K J, Nuyttens, J, Paardekooper, G M R M, Patijn, G A, van der Sangen, M J C, de Vos-Geelen, J, Wilmink, J W, Zwinderman, A H, Punt, C J, van Tienhoven, G & van Eijck, C H J 2022, ' Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer : Long-Term Results of the Dutch Randomized PREOPANC Trial ', Journal of Clinical Oncology, vol. 40, no. 11, pp. 1220-1230 . https://doi.org/10.1200/JCO.21.02233
Journal of Clinical Oncology, 40(11), 1220-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of clinical oncology, 40(11), 1220-1230. American Society of Clinical Oncology

PURPOSE The benefit of neoadjuvant chemoradiotherapy in resectable and borderline resectable pancreatic cancer remains controversial. Initial results of the PREOPANC trial failed to demonstrate a statistically significant overall survival (OS) benefi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c80077a065c4bb8306a86eb726545e
http://www.scopus.com/inward/record.url?scp=85125798289&partnerID=8YFLogxK

NRG Oncology International Consensus Atlas on Target Volumes for Dose-Escalated Pancreatic Cancer Radiotherapy

Autor: Sanford, N.N., Aguilera, T.A., Bassetti, M.F., Chuong, M.D., Erickson, B.A., Goodman, K.A., Herman, J.M., Hong, T.S., Intven, M.P.W., Kilcoyne, A., Kim, H., Narang, A., Paulson, E.S., Reyngold, M., Tsai, S., Tchelebi, L., Tuli, R., Versteijne, E., Wei, A., Wo, J.Y., Zhang, Y., Hall, W.A.

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics 1 October 2024 120(2) Supplement:S144-S144

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer

Autor: Versteijne, E., Suker, M., Groothuis, K., Akkermans-Vogelaar, J.M., Besselink, M.G., Bonsing, B.A., Buijsen, J., Busch, O.R., Creemers, G.J.M., Dam, R.M. van, Eskens, F.A.L.M., Festen, S., Groot, J.W.B. de, Koerkamp, B.G., Hingh, I.H. de, Homs, M.Y.V., Hooft, J.E. van, Kerver, E.D., Luelmo, S.A.C., Neelis, K.J., Nuyttens, J., Paardekooper, G.M.R.M., Patijn, G.A., Sangen, M.J.C. van der, Vos-Geelen, J. de, Wilmink, J.W., Zwinderman, A.H., Punt, C.J., Eijck, C.H. van, Tienhoven, G. van, Dutch Pancreatic Canc Grp

Publikováno v: Journal of Clinical Oncology, 38(16), 1763-1773. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 38(16), 1763-1773. American Society of Clinical Oncology
Journal of Clinical Oncology, 38(16), 1763-1773. American Society of Clinical Oncology
J Clin Oncol

PURPOSE Preoperative chemoradiotherapy may improve the radical resection rate for resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven. PATIENTS AND METHODS In this randomized phase III trial in 16 centers, patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28808dd04ae7ac931715c0e523a5f9c5
https://doi.org/10.1200/jco.19.02274

Emerging insights on neoadjuvant chemoradiotherapy in pancreatic cancer

Autor: Versteijne, E.

The overall survival of patients with resectable or borderline-resectable pancreatic ductal adenocarcinoma (PDAC) has hardly improved over the last decade with a rise in studies investigating the role of preoperative (neoadjuvant) chemoradiotherapy.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::439c54aea1a34cae66a33ef8ec8ae7d7
https://pure.amc.nl/en/publications/emerging-insights-on-neoadjuvant-chemoradiotherapy-in-pancreatic-cancer(d06c2308-8737-4200-9545-90798fdd3c1a).html